Cytyc to Hold Earnings Call on January 28, 2004.Business Editors/Health/Medical Writers BOXBOROUGH, Mass.--(BUSINESS WIRE)--Jan. 21, 2004 Cytyc Cytyc Corporation (NASDAQ: CYTC) engages in the design, development, manufacture, and marketing of clinical products that focus on women’s health. Its products cover a range of women's health applications, including cervical cancer screening, breast cancer risk Corporation (Nasdaq:CYTC) today announced plans to release its fourth quarter 2003 results on Wednesday, January 28, 2004, after the close of the market. In conjunction with the release, management will host a conference call the same day at 5:30 p.m. (Eastern). The call will be simultaneously broadcast over the Internet Internet Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the . Interested participants may listen to a live webcast of the call from Cytyc's web site at http://ir.cytyc.com. Web participants are encouraged to go to the web site at least 15 minutes prior to the start of the call to register, download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer. , and install any necessary audio software. Those without web access may contact Cytyc at 978-929-3322 for dial-in instructions to access the call. After the live webcast, the call will remain available on Cytyc's web site, http://ir.cytyc.com, until February 9, 2004. A telephonic replay of the call will also be available through the same date by calling 973-341-3080 (Reservation No.: 4422574). International participants may use the same number and reservation number. During the call, Patrick Sullivan, Cytyc Corporation's chairman, president, and chief executive officer, Daniel Levangie, executive vice president, Leslie Teso-Lichtman, vice president and acting chief financial officer, and Chris Bleck, vice president of commercial operations, will provide an overview of the fourth quarter financial performance, business highlights, and future expectations. Cytyc Corporation designs, develops, manufactures, and markets the ThinPrep ThinPrep™ Cytology A proprietary system–Cytec, Inc, in which specimens are obtained with a special fluid collection system and the slides for cytologic examination are spread in one-cell-thick layers. See thin prep. (R) System for use in medical diagnostic applications primarily focused on women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. . The ThinPrep System is widely used for cervical cancer Cervical Cancer Definition Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably, forming tumors. screening and is the platform from which the Company has launched its expansion into breast cancer risk assessment with the FirstCyte(R) Breast Test. The ThinPrep System consists of the ThinPrep(R) 2000 Processor, ThinPrep(R) 3000 Processor, ThinPrep(R) Imaging System, and related reagents, filters, and other supplies. Cytyc is traded on The Nasdaq Stock Market Nasdaq stock market The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies. under the symbol CYTC. Cytyc, ThinPrep, and FirstCyte are registered trademarks of Cytyc Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion